TY - JOUR
T1 - Pregnancy Outcomes in Women Screened for Tuberculosis Infection in Swedish Antenatal Care
AU - Walles, John
AU - Winqvist, Niclas
AU - Hansson, Stefan R.
AU - Sturegård, Erik
AU - Baqir, Haitham
AU - Westman, Anna
AU - Kjerstadius, Torbjörn
AU - Schön, Thomas
AU - Björkman, Per
PY - 2024/1
Y1 - 2024/1
N2 - Background: Tuberculosis (TB) disease has been associated with pregnancy complications. However, the potential impact of TB infection (TBI) on pregnancy outcome is unknown. To investigate this, we conducted a register-based study in immigrant women screened with QuantiFERON assays for TBI in antenatal care in Sweden. Methods: Women with history of immigration from TB-endemic countries were eligible for inclusion if national identification numbers and available QuantiFERON results obtained during pregnancy from 2014 to 2018 were available. QuantiFERON results were linked to data on maternal characteristics and pregnancy outcomes from the national Pregnancy and Patient Registers. TBI was defined as nil-corrected QuantiFERON result ≥0.35 IU/mL, in the absence of TB disease. Pregnancies in women with TB disease or human immunodeficiency virus were excluded, as were multiplex pregnancies, pregnancies resulting in miscarriage, and pregnancies occurring >10 years after immigration. Odds of defined adverse pregnancy outcomes were compared by maternal TBI status using mixed effects logistic regression with adjustment for maternal age and region of origin. Results: In total, 7408 women with 12 443 pregnancies were included. In multivariable analysis, stillbirth (adjusted odds ratio [AOR], 1.90; 95% confidence interval [CI], 1.13-3.21; P =. 016), severe preeclampsia (AOR, 1.62; 95% CI, 1.03-2.56; P =. 036), low birthweight (<2500 g; AOR, 1.38; 95% CI, 1.01-1.88; P =. 041), and emergency cesarean section (AOR, 1.28; 95% CI, 1.02-1.63; P =. 033) were significantly associated with TBI. Conclusions: Among immigrant women seeking antenatal care in Sweden, TBI was independently associated with adverse pregnancy outcomes. Further studies are needed to corroborate these findings and to explore mechanisms involved.
AB - Background: Tuberculosis (TB) disease has been associated with pregnancy complications. However, the potential impact of TB infection (TBI) on pregnancy outcome is unknown. To investigate this, we conducted a register-based study in immigrant women screened with QuantiFERON assays for TBI in antenatal care in Sweden. Methods: Women with history of immigration from TB-endemic countries were eligible for inclusion if national identification numbers and available QuantiFERON results obtained during pregnancy from 2014 to 2018 were available. QuantiFERON results were linked to data on maternal characteristics and pregnancy outcomes from the national Pregnancy and Patient Registers. TBI was defined as nil-corrected QuantiFERON result ≥0.35 IU/mL, in the absence of TB disease. Pregnancies in women with TB disease or human immunodeficiency virus were excluded, as were multiplex pregnancies, pregnancies resulting in miscarriage, and pregnancies occurring >10 years after immigration. Odds of defined adverse pregnancy outcomes were compared by maternal TBI status using mixed effects logistic regression with adjustment for maternal age and region of origin. Results: In total, 7408 women with 12 443 pregnancies were included. In multivariable analysis, stillbirth (adjusted odds ratio [AOR], 1.90; 95% confidence interval [CI], 1.13-3.21; P =. 016), severe preeclampsia (AOR, 1.62; 95% CI, 1.03-2.56; P =. 036), low birthweight (<2500 g; AOR, 1.38; 95% CI, 1.01-1.88; P =. 041), and emergency cesarean section (AOR, 1.28; 95% CI, 1.02-1.63; P =. 033) were significantly associated with TBI. Conclusions: Among immigrant women seeking antenatal care in Sweden, TBI was independently associated with adverse pregnancy outcomes. Further studies are needed to corroborate these findings and to explore mechanisms involved.
KW - latent tuberculosis infection
KW - preeclampsia
KW - pregnancy
KW - stillbirth
KW - tuberculosis
U2 - 10.1093/cid/ciad465
DO - 10.1093/cid/ciad465
M3 - Article
C2 - 37572363
AN - SCOPUS:85183651129
SN - 1058-4838
VL - 78
SP - 125
EP - 132
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -